Title: Denervation, Hyperinnervation, and Interactive Regulation of Dopamine and Serotonin Receptors<sup>a</sup>
Abstract: Annals of the New York Academy of SciencesVolume 757, Issue 1 p. 293-310 Denervation, Hyperinnervation, and Interactive Regulation of Dopamine and Serotonin Receptors† TOMÁS A. READER, Corresponding Author TOMÁS A. READER Department of Physiology, Faculty of Medicine University of Montreal Montreal, Quebec, Canada H3C 3J7Dr. Tomás A. Reader, Département de physiologie, Faculté de Médecine, Université de Montréal, C.P. 6128, Succ. Centre-ville, Montréal, Québec H3C 357, Canada.Search for more papers by this authorFATIHA RADJA, FATIHA RADJA Department of Physiology, Faculty of Medicine University of Montreal Montreal, Quebec, Canada H3C 3J7Search for more papers by this authorKAREN M. DEWAR, KAREN M. DEWAR Department of Psychiatry, Faculty of Medicine University of Montreal Montreal, Quebec, Canada H3C 3J7Search for more papers by this authorLAURENT DESCARRIEY, LAURENT DESCARRIEY Department of Pathology Faculty of Medicine University of Montreal Montreal, Quebec, Canada H3C 3J7Search for more papers by this author TOMÁS A. READER, Corresponding Author TOMÁS A. READER Department of Physiology, Faculty of Medicine University of Montreal Montreal, Quebec, Canada H3C 3J7Dr. Tomás A. Reader, Département de physiologie, Faculté de Médecine, Université de Montréal, C.P. 6128, Succ. Centre-ville, Montréal, Québec H3C 357, Canada.Search for more papers by this authorFATIHA RADJA, FATIHA RADJA Department of Physiology, Faculty of Medicine University of Montreal Montreal, Quebec, Canada H3C 3J7Search for more papers by this authorKAREN M. DEWAR, KAREN M. DEWAR Department of Psychiatry, Faculty of Medicine University of Montreal Montreal, Quebec, Canada H3C 3J7Search for more papers by this authorLAURENT DESCARRIEY, LAURENT DESCARRIEY Department of Pathology Faculty of Medicine University of Montreal Montreal, Quebec, Canada H3C 3J7Search for more papers by this author First published: May 1995 https://doi.org/10.1111/j.1749-6632.1995.tb17487.xCitations: 6 † This research was supported by grants from the Medical Research Council of Canada to Drs. Tomás A. Reader and Laurent Descarries, and from the Banting Research Foundation and the Natural Sciences and Engineering Research Council of Canada to Dr. Karen M. Dewar. K.M.D. was supported by a Chercheur-boursier Junior 1 scholarship from the FRSQ, and F.R. by postdoctoral fellowships from the FRSQ and the Groupe FCAR de recherche sur le système nerveux central. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Ungerstedt , U. 1968. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5: 107–110. 2 Urestky , N. J. & L. L. Iversen. 1970. Effects of 6-hydroxydopamine on catecholamine containing neurons in the rat brain. J. Neurochem. 17: 269–278. 3 Zigmond , M. J. & E. M. Stricker. 1989. Animal models of parkinsonism using selective neurotoxins: Clinical and basic implications. Int. Rev. Neurobiol. 31: 1–79. 4 Ungerstedt , U. 1971. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. Suppl. 367: 95–122. 5 Zigmond , M. J. & E. M. Stricker. 1972. Deficits in feeding behaviour after intraventricular injection of 6-hydroxydopamine in rats. Science 177: 1211–1214. 6 Zigmond , M. J., T. G. Hastings & E. D. Abercrombie. 1992. Neurochemical responses to 6-hydroxydopaminc and l-dopa therapy: Implications for Parkinson's disease. Ann. N. Y. Acad. Sci. 648: 71–86. 7 Agid , Y., F. Javoy & J. Glowinski. 1973. Hyperactivity of remaining dopaminergic neurons after partial destruction of the nigro-striatal dopaminergic system in the rat. Nature 245: 150–151. 8 Zigmond , M. J., A. L. Acheson, M. K. Stachowiak & E. M. Stricker. 1984. Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch. Neurol. 41: 856–861. 9 Altar , C. A., M. R. Marien & J. F. Marshall. 1987. Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: Implications for behavioural recovery from brain injury. J. Neurochem. 48: 390–399. 10 Stachowiak , M. K., R. W. Keller, Jr., E. M. Stricker & M. J. Zigmond. 1987. Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage. J. Neurosci. 7: 1648–1654. 11 Creese , I., D. R. Burt & S. H. Snyder. 1977. Dopamine receptor binding enhancement accompanies lesion-induced behavioural supersensitivity. Science 197: 596–598. 12 Neve , K. A., M. R. Kozlowski & J. F. Marshal. 1982. Plasticity of neostriatal dopamine receptors after nigrostriatal injury: Relationship to recovery of sensorimotor functions and behavioural supersensitivity. Brain Res. 244: 33–44. 13 Breese , G. R., A. A. Baumeister, T. J. McCown, S. G. Emerick, G. D. Frye, K. Crotty & R. A. Mueller. 1984. Behavioural differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonist: Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J. Pharmacol. Exp. Ther. 231: 343–354. 14 Johnson , B. J. & J. P. Bruno. 1990. D1 and D2 receptor contributions to ingestive and locomotor behavior are altered after dopamine depletions in neonatal rats. Neurosci. Lett. 118: 120–123. 15 Stachowiak , M. K., J. P. Bruno, A. M. Snyder, E. M. Stricker & M. J. Zigmond. 1984. Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res. 291: 164–167. 16 Berger , T. W., S. Kaul, E. M. Stricker & M. J. Zigmond. 1985. Hyperinnervation of the striatum by dorsal raphe afferents after dopamine-depleting brain lesions in neonatal rats. Brain Res. 336: 354–358. 17 Snyder , A. M., M. J. Zigmond & R. D. Lund. 1986. Sprouting of serotoninergic afferents into striatum after dopamine-depleting lesions in infant rats: A retrograde transport and immunocytochemical study. J. Comp. Neurol. 245: 274–281. 18 Descarries , L., J.-J. Soghomonian, S. Garcia, G. Doucet & J. P. Bruno. 1992. Ultrastructural analysis of the serotonin hyperinnervation in adult rat neostriatum following neonatal dopamine denervation with 6-hydroxydopamine. Brain Res. 569: 1–13. 19 Paré, M., L. Descarries & R. Quirion. 1992. Up-regulation of 5-hydroxytryptamine-2 and NK-1 receptors associated with serotonin/substance P hyperinnervation in the rat inferior olive. Neuroscience 51: 97–106. 20 Breese , G. R. & T. D. Traylor. 1971. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine. Br. J. Pharmacol. 42: 88–99. 21 Bruno , J. P., E. M. Stricker & M. J. Zigmond. 1985. Rats given dopamine-depleting brain lesions as neonates are subsensitive to dopaminergic antagonists as adults. Behav. Neurosci. 99: 771–775. 22 Dewar , K. M., J.-J. Soghomonian, J. P. Bruno, L. Descarries & T. A. Reader. 1990. Elevation of dopamine D2 but not D1 receptors in adult rat neostriatum after neonatal 6-hydroxydopamine denervation. Brain Res. 536: 287–296. 23 Radja , F., L. Descarries, K. M. Dewar & T. A. Reader. 1993. Serotonin 5-HT1 and 5-HT2A receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: A quantitative autoradiographic study. Brain Res. 606: 271–285. 24 Radja , F., M. El Mansari, J.-J. Soghomonian, K. M. Dewar, A. Ferron, T. A. Reader & L. Descarries. 1993. Changes of D1 and D2 receptors in adult rat neostriatum after neonatal dopamine denervation: Quantitative data from ligand binding, in situ hybridization and iontophoresis. Neuroscience 57: 635–648. 25 Molina-Holgado, E., K. M. Dewar, L. Grondin, N. M. van Gelder & T. A. Reader. 1993. Amino acid levels and GABAA receptors in rat neostriatum, cortex and thalamus after neonatal 6-hydroxydopamine lesion. J. Neurochem. 60: 23–32. 26 Molina-Holgado, E., K. M. Dewar, L. Descarries & T. A. Reader. 1994. Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 270: 713–721. 27 Marcinkiewicz , M., D. Vergé, H. Gozlan & M. Hamon. 1984. Autoradiographic evidence for the heterogeneity of 5-HT1 sites in rat brain. Brain Res. 291: 159–163. 28 Köhler, C. & A. C. Radestäter. 1986. Autoradiographic visualization of D2 receptors in monkey brain using the selective benzamide drug [3H]raclopride. Neurosci. Lett. 66: 85–90. 29 Dawson , T. M., D. R. Gehlert, H. I. Yamamura, A. Barnett & J. K. Wamsley. 1985. D1 dopamine receptors in the rat brain: Autoradiographic localization using [3H]SCH 23390. Eur. J. Pharmacol. 108: 323–325. 30 Broaddus , W. C. & J. P. Bennett. 1990. Postnatal development of striatal dopamine function. II. Effects of postnatal 6-hydroxydopamine treatment on D1 and D2 receptors, adenylate cyclase activity and postsynaptic dopamine function. Dev. Brain Res. 52: 273–277. 31 Gelbard , H. A., M. H. Teicher, R. J. Baldessarini, A. Galitano, E. R. Marsh, J. Zorc & G. Faedda. 1990. Dopamine D1 receptor development depends on endogenous dopamine. Dev. Brain Res. 56: 137–140. 32 Breese , G. R., G. R. Duncan, T. C. Napier, S. C. Bondy, L. C. Iorio & R. A. Mueller. 1987. 6-Hydroxydopamine treatment enhances behavioral responses to intracerebral microinjection of D1 and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. J. Pharmacol. Exp. Ther. 240: 167–176. 33 Luthman , J., E. Lindqvist, D. Young & R. Cowburn. 1990. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopaminc receptor binding or dopamine- and adenosine-3′:5′-inonophosphate-regulated phosphoprotein (DARP-32) immunoreactivity. Exp. Brain Res. 83: 85–95. 34 Voorn , P., A. Kalsbeck, B. Jorritsma-Byham & H. J. Groenewegen. 1988. The pre-and postnatal development of the dopaminergic cell groups in the ventral rnesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25: 857–887. 35 Murrin , L. C. & W. Zing. 1989. Dopamine D1 receptor development in the rat striatum: Early localization in striosornes. Brain Res. 480: 170–177. 36 Blunt , S. B., P. Jenner & C. D. Marsden. 1992. Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatments with l-DOPA and carbidopa. Brain Res. 582: 299–311. 37 Joyce , J. N. 1991. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopaminc or colchicine microinjections into TVA or reserpine treatment. Exp. Neurol. 113: 277–290. 38 Savasta , M., A. Dubois, J. Benavidez & B. Scatton. 1988. Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic neurotransmission. Neurosci. Lett. 85: 119–124. 39 Castaneda , E., I. Q. Whishaw, L. Lermer & T. E. Robinson. 1990. Doparnine depletion in neonatal rats: Effects on behavior and striatal dopamine release assessed by intracerebral microdialysis during adulthood. Brain Res. 508: 30–39. 40 Ennis , C., J. D. Kemp & B. Cox. 1981. Characterization of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. J. Neurochem. 36: 1515–1520. 41 Feln , P. & J. De Champlain. 1972. Enhanced sensitivity of caudate neurones to microiontophoretic injections of doparnine in 6-hydroxydopamine treated cats. Brain Res. 43: 601–605. 42 Schultz , W. & U. Ungerstedt. 1978. Striatal cell supersensitivity to apomorphine in dopamine-lesioned rats correlated to behavior. Neuropharrnacology 17: 180–186. 43 Hu , X. T. & R. W. Wang. 1988. Comparison of effects of D1 and D2 dopamine receptor agonists on neurons in the rat caudate putamen: An electrophysiological study. J. Neurosci. 8: 4340–4348. 44 Battaglia , G., A. B. Norman, E. J. Hess & I. Creese. 1986. Functional recovery of D1 dopamine receptor-mediated stimulation of rat striatal adenylate cyclase activity following irreversible receptor modification by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): Evidence for spare receptors. Neurosci. Lett. 69: 290–295. 45 Parenti , M., S. Gentleman, C. Olianas & N. H. Neff. 1982. The dopamine receptor adenylate cyclase complex: Evidence for post recognition site involvemcnt for development of supersensitivity. Neurochem. Res. 7: 115–124. 46 Hess , E. J., L. J. Albers, L. Hoang & I. Creese. 1986. Effects of chronic SCH 23390 treatment on the biochemical and behavioral properties of D1 and D2 dopaminc receptors: Potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. J. Pharmacol. Exp. Ther. 238: 846–851. 47 Carli , M., M. B. Anand-Srivastava, E. Molina-Holgado, K. M. Dewar & T. A. Reader. 1994. Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets. Neurochem. Int. 24: 13–22. 48 Breese , G. R., A. Baumeister, T. C. Napier, G. D. Frye & K. A. Mueller. 1985. Evidence that D1-dopamine receptors contribute to the supersensitive behavioral responses induced by l-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. J. Pharmacol. Exp. Ther. 253: 287–288. 49 Criswell , H., R. A. Mueller & G. R. Breese. 1989. Priming of D1-dopaminc receptor responses: Long-lasting behavioral supersensitivity to a D1 -dopamine agonist foollowing repeated administration to neonatal 6-OHDA-lesioned rats. J. Neurosci. 9: 125–133. 50 Savasta , M., A. Dubois, C. Feuerstein, M. Manier & B. Scatton. 1987. Denervation super-sensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum. Neurosci. Lett. 74: 180–186. 51 Morelli , M., T. Mennini & G. DI Chiara. 1988. Nigral doparnine autoreceptors are exclusively of the D2 type: Quantitative autoradiography of [125I]iodosulpiride and [125I]SCH 23982 in adjacent brain sections. Neuroscience 27: 865–870. 52 Creese , I., D. R. Sibley & S. X. Xu. 1992. Expression of rat striatal D1 and D2 dopamine receptor mRNAs: Ontogenic and pharmacological studies. Neurochem. Int. 20: 45S–48S. 53 Chen , J. F. & B. Weiss. 1986. Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatum. Dev. Brain. Res. 63: 95–104. 54 Soghomonian , J.-J. 1993. Effects of 6-hydroxydopamine injections on glutamate-decarboxylase, prepro-enkephalin and dopamine D2 receptor rnRNAs in the adult rat striatum. Brain Res. 621: 249–259. 55 Goss , J. R., A. B. Kelly, S. A. Johnson & D. G. Morgan. 1991. Haloperidol treatment increases D2 dopamine receptor protein independently of RNA levels in mice. Life Sci. 48: 1015–1022. 56 Van Tol, H. H. M., M. Riva, O. Civelli & I. Creese. 1990. Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level. Neurosci. Lett. 111: 303–308. 57 Mesco , E. R., J. A. Joseph, M. J. Blake & G. S. Roth. 1991. Loss of D2 receptors during aging is partially due to decreased levels of mRNA. Brain Res. 545: 355–358. 58 Sakata , M., S. M. Farooqui & C. Prasad. 1992. Post-transcriptional regulation of loss of rat striatal D2 dopamine receptors during aging. Brain Res. 575: 309–314. 59 Kostrzewa , R. M. & L. Gong. 1991. Supersensitized D1 receptors mediated enhanced oral activity after neonatal 6-OHDA. Pharmacol. Biochern. Behav. 39: 677–682. 60 Verge , D., G. Daval, M. Marcinkiewicz, A. Patey, S. El Mestikawy, H. Gozlan & M. Hamon. 1986. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J. Neurosci. 12: 3474–3482. 61 Pazos , A., D. Hoyer, M. M. Dietl & J. M. Palacios. 1988. Autoradiography of serotonin receptors. In Neuronal Serotonin. N. N. Osborne & M. Hamon, Eds.: 507–543. Wiley. Chichester , UK . 62 Nénonéné, E. K., F. Radja, M. Carli, L. Grondin & T. A. Reader. 1994. Heterogeneity of cortical and hippocampal S-HT1A receptors: A reappraisal of homogenate binding with 8–[3H]hydroxypropyl-arninotetralin. J. Neurochem. 62: 1822–1834. 63 Miquel , M. C., E. Doucet, C. Boni, S. El Mestikawi, L. Matthiessen, G. Daval, D. Vergé & M. Hamon. 1991. Central serotonin1A receptors: Respective distribution of encoding mRNA, receptor protein and binding sites by in situ hibridization histochemistry, radioirnrnunohistochemistry and autoradiographic mapping in the rat brain. Neurochem. Int. 19: 453–465. 64 Riad , M., S. El Mestikawi D. Vergé, H. Gozlan & M. Hamon. 1991. Visualization and quantification of central 5-HT1A receptors with specific antibodies. Neurochern. Int. 19: 413–423. 65 Chalmers , D. T. & S. J. Watson. 1991. Comparative anatomical distribution of S-HT1A receptor mRNA and 5-HT1A binding in rat brain—A comparative in situ hybridization/in vitro receptor autoradiographic study. Brain. Res. 561: 51–60. 66 Gozlan , H., S. El Mestikawi, M. B. Emerit, L. Pichat, J. Glowinski & M. Hamon. 1983. Identification of presynaptic 5-HT autoreceptors using a new ligand: [3H]PAT. Nature 305: 140–142. 67 Hall , M. D., S. El Mestikawi, M. B. Emerit, L. Pichat, M. Hamon & H. Gozlan. 1985. [3H]-8-hydroxy-2(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of rat brain. J. Neurochem. 44: 1685–1696. 68 Pazos , A., G. Engel & J. M. Palacios. 1985. α-Adrenoceptor blocking agents recognize a subpopulation of serotonin receptors in brain. Brain Res. 343: 205–230. 69 Radja , F., G. Daval, M. B. Emerit, M. C. Gallissot, M. Hamon & D. Vergé. 1989. Selective irreversible blockade of 5-hydroxytryptamine1A and 5-hydroxytryptamine1A receptor binding sites in the rat brain by 8-MeO-2′-chloro-PAT: A quantitative autoradiographic study. Neuroscience 31: 723–733. 70 Peroutka , S. J., A. W. Schmidt, A. J. Sleight & M. A. Harrington. 1990. Serotonin receptor "families" in the central nervous system: An overview. In The Neuropharmacology of Serotonin. P. M. Whittaker-Azmitia & S. J. Peroutka, Eds. Ann. N.Y. Acad. Sci. 600: 104–112. 71 Luthman , J., B. Bolioli, T. Tsutsumi, A. Verhofstad & G. Jonsson. 1987. Sprouting of striatal serotonin nerve terminals following selective lesions of nigro-striatal dopamine neurons in neonatal rat. Brain Res. Bull. 19: 269–274. 72 Voigt , M. M., D. J. Laurie, P. H. Seeburg & A. Bach. 1991. Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine1B receptor. EMBO J. 10: 4017–4023. 73 El Mansari, M., F. Radja, A. Ferron, T. A. Reader, E. Molina-Holgado & L. Descarries. 1994. Hypersensitivity to serotonin and its agonists in serotonin-hyperinnervated neostriatum after neonatal dopamine denervation. Eur. J. Pharmacol. 261: 171–178. 74 Hoyer , D., S. Srivasta, A. Pazos, G. Engel & J. M. Palacios. 1986. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding. Neurosci. Lett. 69: 269–274. 75 Pazos , A. & J. M. Palacios. 1985. Quantitative autoradiographic mapping of serotonin receptors in rat brain. I. Serotonin-1 receptors. Brain Res. 346: 205–230. 76 Frazer , A., S. Maayani & B. B. Wolfe. 1988. Subtypes of receptors for serotonin. Annu. Rev. Pharmacol. Toxicol. 30: 307–348. 77 Herrick-Davis, K., I. M. Maisonneuve & M. Titiler. 1989. Postsynaptic localization and up-regulation of serotonin 5-HT1D receptors in rat brain. Brain Res. 483: 155–157. 78 Mengod , G., H. Nguyen, C. Waeber, H. Lübbert & J. M. Palacios. 1990. The distribution and cellular localization of the serotonin1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution. Neuroscience 35: 577–591. 79 Loopuijt , L. D. & D. Van Der Kooy. 1985. Organization of the striatum: Collateralization of its efferent axons. Brain Res. 348: 8699. 80 Gerfen , C. R., T. M. Engber, L. C. Mahan, Z. Susel, T. N. Chase, F. J. Momsma & D. R. Sibley. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Neuroscience 250: 1429–1432. 81 Mc Kenna, D. J., A. J. Nazarali, A. J. Hoffmsn, D. E. Nichols, C. A. Mathis & J. M. Saavedra. 1989. Common receptors for hallucinogens in rat brain: A comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychotomimetic radioligand. Brain Res. 476: 45–56. 82 Blue , M. E., K. A. Yagaloff, L. A. Mamounas, P. R. Hartig & M. E. Molliver. 1988. Correspondence between S-HT2 receptors and serotonergic axons in rat neocortex. Brain Res. 453: 315–328. 83 Mengod , G., M. Pompeinano, I. Martinez-Mir & J. M. Palacios. 1990. Localization of the mRNA for S-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites. Brain Ras. 524: 139–143. 84 Jackson , D. & E. D. Abercrombie. 1992. In vivo neurochemical evaluation of striatal serotonergic hyperinnervation in rats depleted of dopamine at infancy. J. Neurochem. 58: 890–897. Citing Literature Volume757, Issue1Diversity of Interacting ReceptorsMay 1995Pages 293-310 ReferencesRelatedInformation
Publication Year: 1995
Publication Date: 1995-05-01
Language: en
Type: review
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 15
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot